EUVIMEDEUVIMED entdecken
Open Access

Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced‐Fit Docking Analysis

Serpil Gerni iD

Biotechnology and Applied Biochemistry · 2026-08 · 73 (4) · 2079-2091

DOI: 10.1002/bab.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, online erschienen am 23.03.2026. Verfasst von Serpil Gerni. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Ataturk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Hypoglycemic Agents, Aldehyde Reductase, alpha-Amylases. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bromophenol derivatives were evaluated for their inhibitory effects on three key enzymes associated with diabetes: aldose reductase (AR), α‐glycosidase, and α‐amylase. In vitro enzyme inhibition assays revealed that Compound 6 exhibited the strongest α‐glycosidase inhibition (IC 50 = 11.948 nM), while Compound 5 showed the highest potency against AR (IC 50 = 1.386 µM) and α‐amylase (IC 50 = 5.588 nM). Selected compounds (5, 6, 7, and 10) displayed low cytotoxicity against normal human fibroblast cells, indicating favorable safety profiles. Complementary induced‐fit molecular docking analyses supported the experimental results, highlighting specific interactions between the compounds and the enzyme active sites. These findings demonstrate that bromophenol derivatives possess significant enzyme‐inhibitory potential and may serve as promising multifunctional agents for diabetes management. Induced‐fit docking studies revealed that Compounds 6, 10, 5, and 7 exhibited the most favorable binding energies across the tested enzymes, consistent with their high inhibitory potential. Compounds 6 and 10 showed strong α‐glucosidase binding through key interactions such as π–π stacking with TRP539/PHE575 and TRP406, as well as extensive hydrogen and halogen bonding with catalytic residues including TYR299, ASP203, ASP327, and ARG526. Similarly, Compounds 5 and 7 formed stable docking poses within α‐amylase and aldose reductase via multiple hydrogen bonds, halogen contacts, and π–π stacking with crucial residues like ASP197, GLH233, ASN160, TRP20, and TRP219, highlighting their strong affinity and target‐specific interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationHypoglycemic AgentsAldehyde Reductasealpha-AmylasesEnzyme InhibitorsPhenolsHumansalpha-GlucosidasesStructure-Activity Relationship

Stichwörter der Autor:innen

aldose reductasediabetesmolecular dockingα‐amylaseα‐glycosidase

Substanzen

Hypoglycemic AgentsAldehyde Reductasealpha-AmylasesEnzyme Inhibitorsalpha-GlucosidasesPhenols

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Ataturk University, Erzurum, Turkey.

ORCID-Profile: Serpil Gerni

Zitieren

APA

Gerni, S. (2026). Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced‐Fit Docking Analysis. Biotechnology and Applied Biochemistry, 73(4), 2079-2091. https://doi.org/10.1002/bab.70156

Vancouver

Gerni S. Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced‐Fit Docking Analysis. Biotechnology and Applied Biochemistry. 2026;73(4):2079-2091. doi:10.1002/bab.70156

BibTeX
@article{Gerni2026,
  author = {Gerni, Serpil},
  title = {Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced‐Fit Docking Analysis},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2026},
  volume = {73},
  number = {4},
  pages = {2079--2091},
  doi = {10.1002/bab.70156}
}
Kostenlos starten →